The Opioid Epidemic: Moving Toward an Integrated, Holistic Analytical Response
Open Access
- 27 August 2018
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Analytical Toxicology
- Vol. 43 (1), 1-9
- https://doi.org/10.1093/jat/bky049
Abstract
In many jurisdictions, public safety and public health entities are working together to enhance the timeliness and accuracy of the analytical characterization and toxicology testing of novel synthetic opioids. The improved sharing and early detection of these analytical data are intended to inform surveillance, interdiction efforts, patient intervention and treatment, all of which are critical to curbing the opioid epidemic. Forensic practitioners working to identify novel synthetic opioids struggle to provide timely results when encountering new or unknown substances, such as the fentanyl analogs. These compounds, which mimic heroin in pharmacologic effect but can be far more potent, are inconsistently present in chemical identification libraries, and are currently largely unavailable as reference materials for analytical comparison. Additionally, federal, state and local governments as well as nongovernmental organizations require potency, toxicity and potential-for-abuse data to evaluate the potential health risks of emerging drug threats. Subsequent scheduling efforts and criminal prosecutions also require these thorough drug characterization studies. Pilot programs have demonstrated that early communication of real-time drug toxicity and analytical data significantly impacts the successful response to emerging opioids. High-quality, real-time, national-level data on chemical composition, toxicological test data, drug toxicity and overdoses, and analysis of seized materials by law enforcement are needed to track drug trends. However, the USA still lacks a national system to coordinate and communicate toxicology, medical and medical examiner and coroner data with the broader medical and law enforcement communities. Opportunities to address these gaps as well as recent advancements collected through interagency efforts and technical workshops in the toxicology and analytical chemistry communities are presented here. Opportunities for partnership, increased communication and expanding best practices to move toward an integrated, holistic analytical response are also explored.Keywords
This publication has 24 references indexed in Scilit:
- Non-targeted screening for novel psychoactive substances among agitated emergency department patientsClinical Toxicology, 2016
- Acetyl Fentanyl, a Novel Fentanyl Analog, Causes 14 Overdose Deaths in Rhode Island, March–May 2013Journal of Medical Toxicology, 2015
- The Potential Threat of Acetyl Fentanyl: Legal Issues, Contaminated Heroin, and Acetyl Fentanyl “Disguised” as Other OpioidsAnnals of Emergency Medicine, 2014
- Fentanyl-Related Compounds and Derivatives: Current Status and Future Prospects for Pharmaceutical ApplicationsFuture Medicinal Chemistry, 2014
- Complete Republication: National Association of Medical Examiners Position Paper: Recommendations for the Investigation, Diagnosis, and Certification of Deaths Related to Opioid DrugsJournal of Medical Toxicology, 2013
- Role of liquid chromatography–high-resolution mass spectrometry (LC-HR/MS) in clinical toxicologyClinical Toxicology, 2012
- Toxicity Testing in the 21st Century: A Vision and a StrategyJournal of Toxicology and Environmental Health, Part B, 2010
- “Med-X”: a medical examiner surveillance model for bioterrorism and infectious disease mortalityHuman Pathology, 2007